Correlation Between Molecular Partners and Apeiron Capital

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Molecular Partners and Apeiron Capital at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Molecular Partners and Apeiron Capital into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Molecular Partners AG and Apeiron Capital Investment, you can compare the effects of market volatilities on Molecular Partners and Apeiron Capital and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Molecular Partners with a short position of Apeiron Capital. Check out your portfolio center. Please also check ongoing floating volatility patterns of Molecular Partners and Apeiron Capital.

Diversification Opportunities for Molecular Partners and Apeiron Capital

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Molecular and Apeiron is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Molecular Partners AG and Apeiron Capital Investment in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Apeiron Capital Inve and Molecular Partners is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Molecular Partners AG are associated (or correlated) with Apeiron Capital. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Apeiron Capital Inve has no effect on the direction of Molecular Partners i.e., Molecular Partners and Apeiron Capital go up and down completely randomly.

Pair Corralation between Molecular Partners and Apeiron Capital

If you would invest  487.00  in Molecular Partners AG on November 4, 2024 and sell it today you would earn a total of  29.00  from holding Molecular Partners AG or generate 5.95% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy0.0%
ValuesDaily Returns

Molecular Partners AG  vs.  Apeiron Capital Investment

 Performance 
       Timeline  
Molecular Partners 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Molecular Partners AG has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest uncertain performance, the Stock's essential indicators remain healthy and the recent disarray on Wall Street may also be a sign of long period gains for the firm investors.
Apeiron Capital Inve 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Apeiron Capital Investment has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable fundamental indicators, Apeiron Capital is not utilizing all of its potentials. The current stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

Molecular Partners and Apeiron Capital Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Molecular Partners and Apeiron Capital

The main advantage of trading using opposite Molecular Partners and Apeiron Capital positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Molecular Partners position performs unexpectedly, Apeiron Capital can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Apeiron Capital will offset losses from the drop in Apeiron Capital's long position.
The idea behind Molecular Partners AG and Apeiron Capital Investment pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.

Other Complementary Tools

Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments